The Rise of TMVII: Navigating a New Landscape in Sexually Transmitted Infections
A recent surge in cases of Trichophyton mentagrophytes genotype VII (TMVII), a sexually transmitted fungus causing ringworm, is prompting increased vigilance among healthcare professionals. More than 30 cases were recently reported in Minnesota, signaling a potential broadening outbreak. This infection, easily mistaken for other skin conditions, demands a renewed focus on accurate diagnosis and public awareness.
Understanding TMVII: Symptoms and Misdiagnosis
TMVII presents as “round, coin-like rashes that are red and irritated, sometimes with bumps and pimples,” according to the Minnesota Department of Health. However, its ability to mimic eczema, psoriasis, and bacterial skin infections often leads to misdiagnosis. This represents further complicated by the fact that tinea infections can appear atypical, especially when treated inappropriately with topical steroids, potentially masking classic features.
Pro Tip: When encountering a persistent or atypical rash, especially in sexually active individuals, consider TMVII as a potential diagnosis and pursue appropriate testing.
A Global Perspective: From Europe to the US
While the first U.S. Case was reported in New York City in 2024, TMVII has circulated in Europe for several years. The CDC notes a correlation with individuals who have engaged in sex tourism in Southeast Asia, and the infection tends to be more prevalent among men who have sex with men. Minnesota’s first reported case surfaced in July 2025.
The Diagnostic Challenge: Why TMVII is Tricky
Accurate diagnosis can be challenging. Clinicians must consider that tinea can present atypically, even in the genital area. While a KOH prep can be performed to check for fungus, it isn’t always conclusive. Cultures can be collected, but results seize time and aren’t always positive.
“We need to remember if a patient isn’t responding as expected to treatment…we need to step back and consider tinea among other diagnoses,” explains Avrom S. Caplan, MD, associate professor of dermatology at NYU Grossman School of Medicine.
Differentiating TMVII from Syphilis
Syphilis, often called “the great mimicker,” can present with similar symptoms. Clinicians should consider testing for syphilis alongside TMVII, particularly when sexual transmission is suspected. Even after a TMVII diagnosis, ruling out other sexually transmitted infections remains crucial.
Treatment and Prevention: A Multi-Faceted Approach
TMVII is treatable with oral antifungals. However, treatment can be prolonged, especially if the infection has been present for some time or if prior treatments have been ineffective. Education is key to preventing further outbreaks. Clear communication about potential transmission during treatment is essential.
Did you know? You’ll see reports suggesting a potential period of asymptomatic spread for TMVII, meaning an individual could transmit the infection before exhibiting symptoms.
Looking Ahead: Potential for Increased Outbreaks
Experts anticipate that increased awareness will lead to more diagnoses and potentially more clustered outbreaks. Continued vigilance, coupled with proactive education for both patients and clinicians, will be vital in managing the spread of TMVII.
Frequently Asked Questions
- What is TMVII? TMVII is a sexually transmitted fungus that causes ringworm.
- How is TMVII diagnosed? Diagnosis can be challenging and may require cultures, though a KOH prep can be a first step.
- Is TMVII treatable? Yes, TMVII is treatable with oral antifungals.
- Can TMVII be mistaken for other conditions? Yes, it can mimic eczema, psoriasis, and bacterial skin infections.
For more information, contact [email protected].
